You are here
Houston Biotechnology, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Drug Assocated Polymer Implants for Ocular Indications
Amount: $100,000.00We will test, in rabbits, implants that slowly release antiproliferative drugs that could improve tocular surgery. In one case the objective is to inhibit the growth of residual lens epithelium afters ...
SBIRPhase I1995Department of Health and Human Services -
Novel Treatment for Intractable Pain
Amount: $50,000.00Intractable pain is chronic pain for which there is little or no effective therapy. We will create a therapeutic agent that will chemically ablate peripheral pain nerves involved in intractable pain a ...
SBIRPhase I1993Department of Health and Human Services -
AN OCULAR NEUROTROPHIC FACTOR TO TREAT GLAUCOMA
Amount: $500,000.00THE CILIARY GANGLION INNERVATES SEVERAL IMPORTANT EYE TISSUES, INCLUDING THE CILIARY MUSCLE AND BODY, AND HAS BEEN SHOWN TO REGULATE AQUEOUS OUTFLOW AND ACCOMMODATION. THE EYE DISORDERS, GLAUCOMA AND ...
SBIRPhase II1992Department of Health and Human Services -
IMMUNOTOXIN TREATMENT OF BLEPHAROSPASM AND STRAABISMUS
Amount: $50,000.00BLEPHAROSPASM AND STRABISMUS ARE CHRONIC, DEBILITATING, OCULAR SPASTIC DISORDERS CAUSED BY UNCONTROLLED OR BALANCED MUSCLE CONTRACTION. THE LONG-TERM OBJECTIVE OF THIS WORK IS TO CREATE A THERAPEUTIC ...
SBIRPhase I1992Department of Health and Human Services -
CONSTRUCTION OF CHICKEN X MOUSE HYBRIDOMAS
Amount: $50,000.00WE WILL CONSTRUCT CHICKEN KH MOUSE HYBRIDOMA CELL LINES SECRETING CHICKEN MABS TO SELECTED ANTIGENS. A PRIMARY ADVANTAGE IN THE CONSTRUCTION OF THESE HYBRIDOMAS IS THE GENETIC DIFFERENCES BETWEEN CHIC ...
SBIRPhase I1992Department of Health and Human Services -
DISULFIDE LINKAGE OF IMMUNOTOXINS BY IGG OLIGOSACCHARIDE
Amount: $50,000.00THE PREPARATION OF IMMUNOTOXINS COMPOSED OF RICIN A AND IMMUNOGLOBULINS HAS CLASSICALLY BEEN PERFORMED WITH HETEROBIFUNCTIONAL CROSSLINKERS SUCH AS N-SUCCINIMIDYL 3-(2-PYRIDYLDITHIO) PROPIONATE (SPDP) ...
SBIRPhase I1992Department of Health and Human Services -
MONOCLONAL ANTIBODY AGAINST 2'-DEOXYCYTIDINE, A PUTATIVE INTRACELLULAR MESSENGER
Amount: $50,000.002'-DEOXYCYTIDINE (DCYT) IS HYPOTHESIZED TO ACT AS AN INTRACELLULAR MESSENGER OF TROPHIC FACTOR SIGNAL TRANSDUCTION AND A MEDIATOR OF NEURONAL DEATH BY A MECHANISMTHAT DOES NOT INVOLVE DNA SYNTHESIS OR ...
SBIRPhase I1991Department of Health and Human Services -
PVR\AN IMMUNOPHARMACOLOGICAL APPROACH TO TREATMENT
Amount: $50,000.00PROLIFERATIVE VITREORETINOPATHY (PVR) IS A POTENTIALLY BLINDING DISEASE CAUSED BY THE MIGRATION INTO AND SUBSEQUENT PROLIFERATION OF RETINAL PIGMENTED EPITHELIAL CELLS (RPE), GLIAL CELLS, FIBROBLASTS ...
SBIRPhase I1991Department of Health and Human Services -
GLAUCOMA FILTERING SURGERY: IMPROVED BY DRUG CONJUGATES
Amount: $50,000.00FILTERING SURGERY, WHEN SUCCESSFUL, IS AN EFFECTIVE METHOD TO REDUCE INTRAOCULAR PRESSURE AND VISUAL FIELD LOSS IN GLAUCOMA PATIENTS. THE CREATION OF A SURGICAL FILTER IN THESE PATIENTS PROVIDES AN AR ...
SBIRPhase I1991Department of Health and Human Services -
IOL-IMMOBILIZED IMMUNOTOXINS TO PREVENT SECONDARY CATARA
Amount: $49,618.00SECONDARY CATARACT RESULTS FROM THE PROLIFERATION OF RESIDUAL LENS EPITHELIAL CELLS FOLLOWING EXTRACAPSULAR CATARACT SURGERY. GROWTH OF THESE CELLS ON THE POSTERIOR CAPSULE SURFACE CAN EVENTUALLY CAUS ...
SBIRPhase I1991Department of Health and Human Services
